US Patent Issued to REMEDOR BIOMED on Sept. 30 for "Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations" (Israeli Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,182, issued on Sept. 30, was assigned to REMEDOR BIOMED LTD. (Nazareth Illit, Israel).

"Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations" was invented by Saher Hamed (Nazareth Illit, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Topical formulations containing erythropoietin (EPO), and also preferably fibronectin (FN), especially gel formulations, are used to accelerate wound healing, e.g., from a burn, compared to the healing process without such a formulation being applied."

The patent was filed on Nov. 29, 2021, under Application No. 17/537,020.

*For further informati...